<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-158304</identifier>
<setSpec>0213-4853</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Impulsivity among migraine patients: study in a series of 155 cases</dc:title>
<dc:description xml:lang="en">Introduction. Impulsivity is a psychological phenomenon that has not been extensively studied in headache patients. We aim to assess the presence of impulsivity in patients with chronic migraine (CM) and medication overuse (MO). Patients. All patients examined in an outpatient headache clinic between January 2013 and March 2014 were included. Episodic migraine, CM, and MO were diagnosed according to ICHD-III beta criteria. We prospectively gathered demographic and clinical characteristics. Mood disorders were evaluated using the Hospital Anxiety and Depression Scale (HADS) and impulsiveness was assessed with the Plutchik impulsivity scale. Results. A total of 155 patients were included (22 men, 133 women). The mean age (SD) was 38.2 (11.7) years (range, 18-70); 104 patients (67.1%) presented CM and, among them, 74 (71.1%) had MO. Of the patient total, 28.4% met criteria for anxiety, 7.1% for depression and 16.1% for impulsivity. The CM group showed higher scores for HADS-anxiety (8.5 [SD 4.5] vs. 6.4 [SD 3.6], p=0.003) and HADS-depression (4.4 [4.3] vs. 1.9 [2.3], p&lt;0.001). Among CM cases only, scores for HADS-anxiety (9.3 [4.4] vs. 6.8 [4.3], p=0.01) and HADS-Depression (5.1 [4.6] vs. 2.7 [2.9], p=0.002) were higher in patients who also had MO. We found no associations between Plutchik scale scores or presence of impulsivity with either CM or MO. Conclusion. Impulsivity is a common trait in our population of migraine patients, but unlike mood disorders, it is not correlated with either CM or MO (AU)</dc:description>
<dc:creator>Ruiz, M</dc:creator>
<dc:creator>Molina, V</dc:creator>
<dc:creator>Domínguez, E</dc:creator>
<dc:creator>Muñoz, I</dc:creator>
<dc:creator>Isidro, G</dc:creator>
<dc:creator>Guerrero, AL</dc:creator>
<dc:creator>Sotelo, EM</dc:creator>
<dc:creator>Uribe, F</dc:creator>
<dc:creator>Mayor, E</dc:creator>
<dc:creator>Hernández, MS</dc:creator>
<dc:creator>Pedraza, MI</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La impulsividad es una dimensión psicológica no estudiada en profundidad en pacientes con cefalea. Pretendemos evaluar su influencia en la presencia de una migraña crónica (MC) o uso excesivo de medicación (UEM). Pacientes. Pacientes atendidos consecutivamente en una consulta de cefaleas (enero de 2013-marzo de 2014). Diagnosticamos migraña episódica, MC o UEM de acuerdo con la Clasificación Internacional de Cefaleas, versión beta de la III edición (CIC-III). Recogimos prospectivamente características demográficas y clínicas. Evaluamos trastornos del ánimo mediante la Escala de Ansiedad y Depresión Hospitalaria (HADS) y la impulsividad con la Escala de Plutchik. Resultados. Ciento cincuenta y cinco pacientes (22 varones, 133 mujeres), edad 38,2±11,7 años (18-70); 104 (67,1%) con MC y entre ellos 74 (71,1%) con UEM. El 28,4% de los 155 pacientes incluidos en la serie cumplía criterios de ansiedad, el 7,1% de depresión, y el 16,1% de impulsividad. Las puntuaciones de las subescalas HADS-ansiedad (8,5±4,5 vs. 6.4±3.6, p: 0.003) y HADS-depresión (4,4±4,3 vs. 1,9±2,3, p&lt;0,001), eran mayores en los casos con MC. Entre los pacientes con MC, HADS-ansiedad (9,3±4,4 vs. 6,8±4,3, p: 0,01) y HADS-depression (5,1±4,6 vs. 2,7±2,9, p: 0,002) eran más altas en aquellos con UEM. No encontramos relación entre la presencia de impulsividad o la puntuación en la Escala de Plutchik y la MC o UEM. Conclusiones. En nuestra población de migrañosos la impulsividad es frecuente, pero, a diferencia de los estados de ánimo, no se correlaciona con MC o UEM (AU)</dc:description>
<dc:source>Neurologia;31(9): 599-605, nov.-dic. 2016. tab</dc:source>
<dc:identifier>ibc-158304</dc:identifier>
<dc:title xml:lang="es">Impulsividad en pacientes migrañosos: estudio en una serie de 155 casos</dc:title>
<dc:subject>^d3883^s22012</dc:subject>
<dc:subject>^d9068^s22016</dc:subject>
<dc:subject>^d1012^s22016</dc:subject>
<dc:subject>^d12018^s22048</dc:subject>
<dc:subject>^d6412^s22016</dc:subject>
<dc:subject>^d7352^s22016</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1012^s22012</dc:subject>
<dc:subject>^d6412^s22012</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d12018^s22083</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d7352^s22012</dc:subject>
<dc:subject>^d1014^s22012</dc:subject>
<dc:subject>^d344^s22031</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d9068^s22011</dc:subject>
<dc:subject>^d9068^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201612</dc:date>
</metadata>
</record>
</ibecs-document>
